These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 28393247)
21. Screening for genes, transcription factors and miRNAs associated with the myogenic and osteogenic differentiation of human adipose tissue-derived stem cells. Quan L; Wang Y; Liang J; Qiu T; Wang H; Zhang Y; Zhang Y; Hui Q; Tao K Int J Mol Med; 2016 Dec; 38(6):1839-1849. PubMed ID: 27779643 [TBL] [Abstract][Full Text] [Related]
22. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. Gao X; Wang X; Zhang S Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341252 [TBL] [Abstract][Full Text] [Related]
23. Analysis of potential key genes in very early hepatocellular carcinoma. Wu M; Liu Z; Li X; Zhang A; Lin D; Li N World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166 [TBL] [Abstract][Full Text] [Related]
24. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665 [TBL] [Abstract][Full Text] [Related]
25. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma. Zhang Y; Wang S; Xiao J; Zhou H Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088 [TBL] [Abstract][Full Text] [Related]
26. Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma. Shi SQ; Ke JJ; Xu QS; Wu WQ; Wan YY Neoplasma; 2018; 65(1):66-74. PubMed ID: 29322790 [TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542 [TBL] [Abstract][Full Text] [Related]
28. CUL4B, NEDD4, and UGT1As involve in the TGF-β signalling in hepatocellular carcinoma. Qu Z; Li D; Xu H; Zhang R; Li B; Sun C; Dong W; Zhang Y Ann Hepatol; 2016; 15(4):568-76. PubMed ID: 27236156 [TBL] [Abstract][Full Text] [Related]
29. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Kishikawa T; Otsuka M; Tan PS; Ohno M; Sun X; Yoshikawa T; Shibata C; Takata A; Kojima K; Takehana K; Ohishi M; Ota S; Noyama T; Kondo Y; Sato M; Soga T; Hoshida Y; Koike K Oncotarget; 2015 Apr; 6(10):8339-52. PubMed ID: 25826076 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses. Liu AG; Pang YY; Chen G; Wu HY; He RQ; Dang YW; Huang ZG; Zhang R; Ma J; Yang LH Technol Cancer Res Treat; 2020; 19():1533033820979670. PubMed ID: 33327879 [TBL] [Abstract][Full Text] [Related]
31. Identification of novel genes associated with fracture healing in osteoporosis induced by Krm2 overexpression or Lrp5 deficiency. Gao F; Xu F; Wu D; Cheng J; Xia P Mol Med Rep; 2017 Jun; 15(6):3969-3976. PubMed ID: 28487939 [TBL] [Abstract][Full Text] [Related]
32. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling. Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF. Zeng Y; Shen Z; Gu W; Wu M Gene; 2018 Apr; 651():183-193. PubMed ID: 29408622 [TBL] [Abstract][Full Text] [Related]
34. Identification of critical genes in nucleus pulposus cells isolated from degenerated intervertebral discs using bioinformatics analysis. Zhu Z; Chen G; Jiao W; Wang D; Cao Y; Zhang Q; Wang J Mol Med Rep; 2017 Jul; 16(1):553-564. PubMed ID: 28586059 [TBL] [Abstract][Full Text] [Related]
35. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Lin J; Wu G; Zhao Z; Huang Y; Chen J; Fu C; Ye J; Liu X Mol Med Rep; 2018 Dec; 18(6):5594-5602. PubMed ID: 30365099 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347 [TBL] [Abstract][Full Text] [Related]
37. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214 [TBL] [Abstract][Full Text] [Related]
38. Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis. Gao B; Zhang X; Huang Y; Yang Z; Zhang Y; Zhang W; Gao ZH; Xue D PLoS One; 2017; 12(3):e0174142. PubMed ID: 28355233 [TBL] [Abstract][Full Text] [Related]
39. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data. Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067 [TBL] [Abstract][Full Text] [Related]
40. Identification of the typical miRNAs and target genes in hepatocellular carcinoma. Han K; Li J; Zhao H; Liang P; Huang X; Zheng L; Li Y; Yang T; Wang L Mol Med Rep; 2014 Jul; 10(1):229-35. PubMed ID: 24789420 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]